Overview

Effects of Antimuscarinics on Cognition in Spinal Cord Injury

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Prospective evaluation of the cognitive function of in-house patients suffering from an acute traumatic spinal cord injury before and three months after the initiation of antimuscarinic treatment. The following hypothesis will be tested: Antimuscarinic treatment results in significantly worse cognitive test results three months after traumatic spinal cord injury compared to the pre-treatment results and the results of the control group.
Details
Lead Sponsor:
Swiss Paraplegic Centre Nottwil
Treatments:
Muscarinic Antagonists